Sort   by:  
 Page size 
UnknownOptimizing Intradermal Administration of Cryopreserved Plasmodium falciparum Sporozoites in Controlled Human Malaria Infection.
Not available
S-EPMC4674246 | biostudies-literature
UnknownSafety and allele-specific immunogenicity of a malaria vaccine in Malian adults: results of a phase I randomized trial.
Not available
S-EPMC1851722 | biostudies-literature
UnknownRepeat controlled human Plasmodium falciparum infections delay bloodstream patency and reduce symptoms.
Not available
S-EPMC11189388 | biostudies-literature
UnknownPfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial.
Not available
S-EPMC9343417 | biostudies-literature
UnknownAtypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans.
Not available
S-EPMC7873835 | biostudies-literature
UnknownPlasmodium falciparum gene expression signatures and antibody profiling implicate the fikk, phist, and surf multigene families in severe malaria syndromes.
Not available
S-EPMC12854251 | biostudies-literature
UnknownSafety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trial.
Not available
S-EPMC2186380 | biostudies-literature
UnknownComparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial.
Not available
S-EPMC10504073 | biostudies-literature
UnknownLow-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial.
Not available
S-EPMC10121890 | biostudies-literature
UnknownImmunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial.
Not available
S-EPMC11032204 | biostudies-literature
Sort   by:  
 Page size